국제 명칭: NitroMed, Inc., Lexington, Massachusetts, United States
브랜드명 / 상호: NitroMed
등록 국가: United States
주소: Massachusetts
설립 연도: 1987
설명:
Former US pharmaceutical company (1987-2009) that developed BiDil, the first FDA-approved race-specific drug, for congestive heart failure; ceased operations in 2009.
평가 & 댓글 남기기